UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
Regarding the stopping, thats nothing to worry about either, read some advice from above, and if you are genuinely concerned ask your mum or someone to take you to the doctors
References: St Pete Urology
A 503A pharmacy compounds patient-specific prescriptions, is licensed by its state board, and fills individual orders
Key quality considerations include: Licensed Peptides does not market or endorse this product for diagnostic, therapeutic, or consumptive purposes
[7] [12] However, Phase 2 trials are not powered to detect rare cardiovascular outcomes, and longer-term Phase 3 data including dedicated cardiovascular outcome trials will be essential to fully characterise the cardiac safety profile of retatrutide